Full Text
Following Norway, Which Market Will Be Next to See Extreme Biosimilar Discounting?

Abstract

Authors

RJ Overington A Kumar O Staples

Back to Volume 18, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×